Oxford Angel Fund — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Granza Biogranzabio.com in 𝕏Feb 2024

Granza Bio develops immunotherapy treatments leveraging naturally-occurring attack particles that are released from cytotoxic immune cells to target diseases including cancers, autoimmunity, and infections.

BiotechDeep TechDigital HealthHealthtechSan Francisco, US

Prof. Dustin(Co-founder)Ashwin Nandakumar(Founder)in Ashwin Jainarayanan(Founder)in Ashwin Menon Nandakumar(Founder)in

Co-investorsFelicis Ventures Metaplanet Oxonian Ventures Pioneer Ritual Capital Y Combinator +4 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.